PAI Holdings, LLC. dba Pharmaceutical Associates Inc recalls Ethosuximide Oral Solution USP 250 mg/5 mL, 16 fl oz (473 mL), Rx ONLY, Pharmaceutical Associates, Inc. Greenville, SC
Recalled August 18, 2021 · FDA recall D-0723-2021 · PAI Holdings, LLC.
Hazard
Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup. · FDA Class II
Units
75 cases (6 bottles/case)
Sold at
Distributed Nationwide in the USA
Description
Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.
Product
Ethosuximide Oral Solution USP 250 mg/5 mL, 16 fl oz (473 mL), Rx ONLY, Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-0670-16
Manufacturer(s)
PAI Holdings, LLC. dba Pharmaceutical Associates Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →